Overview

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection

Status:
Unknown status

Trial end date:
2017-03-01

Target enrollment:

Participant gender:

Summary

To evaluate the therapeutic evaluation of combination therapy with aspirin and salvianolate injection based on the population pharmacokinetics and TEG.A prospective, multicenter, randomized, controlled clinical trial is used.A total of 120 patients will be recruited and will be divided into three groups,respectively salvianolate injection group,aspirin group and salvianolate injection and aspirin group，and the course of treatment is 10 days.

Phase:

Phase 4

Details

Lead Sponsor:

China Academy of Chinese Medical Sciences

Collaborators:

General Hospital of Beijing PLA Military Region
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Guangdong Provincial Hospital of Traditional Chinese Medicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences

Treatments:

Aspirin